[1]
|
Reitz, C. and Mayeux, R. (2014) Alzheimer Disease: Epidemiology, Diagnostic Criteria, Risk Factors and Biomarkers. Biochemical Pharmacology, 88, 640-651.
|
[2]
|
McGeer, P.L. and McGeer, E.G. (2013) The Amyloid Cascade-Inflammatory Hypothesis of Alzheimer Disease: Implications for Therapy. Acta Neuropathologica, 126, 479-497. https://doi.org/10.1007/s00401-013-1177-7
|
[3]
|
Cagnin, A., et al. (2007) Positron Emission Tomography Imaging of Neuroinflammation. Neurotherapeutics, 4, 443- 452.
|
[4]
|
Edison, P., et al. (2008) Microglia, Amyloid and Cognition in Alzheimer’s Disease: An [11C](R)PK11195-PET and [11C]PIB-PET Study. Neurobiology of Disease, 32, 412-419.
|
[5]
|
Okello, A., et al. (2009) Microglia Activation and Amyloid Deposition in Mild Cognitive Impairment: A PET Study. Neurology, 72, 56-62. https://doi.org/10.1212/01.wnl.0000338622.27876.0d
|
[6]
|
Maeda, J., et al. (2007) Longitudinal, Quantitative Assessment of Amyloid, Neuro Inflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer’s Disease Enabled by Positron Emission Tomography. Journal of Neuroscience, 27, 10957-10968. https://doi.org/10.1523/JNEUROSCI.0673-07.2007
|
[7]
|
Doorduin, J., et al. (2009) [(11)C]-DPA-713 and [(18)F]-DPA-714 as New PET Tracers for TSPO: A Comparison with [(11)C]-(R)-PK11195 in a Rat Model of Herpes Encephalitis. Molecular Imaging and Biology, 11, 386-398.
https://doi.org/10.1007/s11307-009-0211-6
|
[8]
|
Griga, T., Kleinw, E.J.T., et al. (2005) CD14 Expression on Monocytes and Soluble CD14 Plasma Levels in Correlation to the Promoter Polymorphism of the Endotoxin Receptor CD14 Gene in Patients with Inactive Crohn’s Disease. Hepatogastroenterology, 52, 808-811.
|
[9]
|
Cao, L., Tanga, F.Y. and Deleo, J.A. (2009) The Contributing Role of CD14 in Toll-Like Receptor 4 Dependent Neuropathic Pain. Neuroscience, 158, 896-903.
|
[10]
|
Fassbender, K., Walter, S., Kuhl, S., et al. (2004) The LPS Receptor (CD 14) Links Innate Immunity with Alzheimer’s Disease. The FASEB Journal, 18, 203-205.
|
[11]
|
Reed-Geaghan, E.G., et al. (2009) CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar A β-Stimulated Microglial Activation. Journal of Neuroscience, 29, 11982. https://doi.org/10.1523/JNEUROSCI.3158-09.2009
|
[12]
|
Walter, S., et al. (2007) Role of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease. Cellular Physiology and Biochemistry, 20, 947-956. https://doi.org/10.1159/000110455
|
[13]
|
Coracii, S., Husemann, J., Berman, J.W., et al. (2002) CD36, Aclass Bscavenger Receptor, Is Expressed on Microglia in Alzheimer’s Disease Brain Sand Can Mediate Production of Reactive Oxygen Species in Response to Be Ta-Amy- loid Fibrils. American Journal of Pathology, 160, 101.
|
[14]
|
Golde, S., Chandran, S., Brown, G.C., et al. (2002) Different Pathways for iNOS-Mediated Toxicity in Vitro Dependent on Neuronalmaturation and NMDA Receptor Rexpression. Journal of Neurochemistry, 82, 269.
https://doi.org/10.1046/j.1471-4159.2002.00973.x
|
[15]
|
Hubacek, J.A., PH’ha, J., Skoclova, Z., et al. (1999) C(-260)T Polymorphism in the Promoter of the CD14 Monocyte Receptor Geneas a Risk Factor for Myocardial Infaration. Circulation, 99, 3218-3220.
https://doi.org/10.1161/01.CIR.99.25.3218
|
[16]
|
Liu, Y., Walter, S., Stagi, M., et al. (2005) LPS Receptor (CD14): A Receptor for Phagocytosis of Alzheimer’ Amyloid Peptide. Brain, 128, 1778-1789.
|
[17]
|
Reed-Geaghan, E.G., et al. (2010) Deletion of CD14 Attenuates Alzheimer’s Disease Pathology by Influencing the Brain’s Inflammatory Milieu. Journal of Neuroscience, 30, 15369-15373.
https://doi.org/10.1523/JNEUROSCI.2637-10.2010
|
[18]
|
Tahara, K., et al. (2006) Role of Toll-Like Receptor Signalling in Aβ Uptake and Clearance. Brain, 129, 3006-3019.
https://doi.org/10.1093/brain/awl249
|
[19]
|
Hickman, S.E., et al. (2008) Microglial Dysfunction and Defective Beta Amyloid Clearance Pathways in Aging Alzheimer’s Disease Mice. Journal of Neuroscience, 28, 8354-8360.
https://doi.org/10.1523/JNEUROSCI.0616-08.2008
|
[20]
|
Zhang, W.,Wang, L.Z.,Yu, J., et al. (2012) Increased Expressions of TLR2 and TLR4 on Peripheral Blood Mononuclear Cells from Patients with Alzheimer’s Disease. Journal of the Neurological Sciences, 315, 67-71.
|
[21]
|
Wu, Z., Zhu, A., Takayama, F., Okada, R., Liu, Y., Harada, Y., Wu, S. and Nakanishi, H. (2013) Brazilian Green Propolis Suppresses the Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia. Oxidative Medicine and Cellular Longevity, 2013, Article ID: 906726.
|
[22]
|
Herber, D.L., et al. (2006) Diverse Microglial Responses after Intrahippocampal Administration of Lipopolysaccharide. Glia, 53, 382-391. https://doi.org/10.1002/glia.20272
|
[23]
|
Quinn, J., et al. (2003) Inflammation and Cerebral Amyloidosis Are Disconnected in an Animal Model of Alzheimer’s Disease. Journal of Neuroimmunology, 137, 32-41.
|
[24]
|
Mawuenyega, K.G., Sigurdson, W., Ovod, V., et al. (2010) Decreased Clearance of CNS Beta-Amyliod in Alzheimer’s Disease. Science, 330, 1774. https://doi.org/10.1126/science.1197623
|
[25]
|
Minogue, A.M., Jones, R.S., Kelly, R.J., et al. (2014) Age-Associated Dysregulation of Microglial Activation Is Coupled with Enhanced Blood-Brain Barrier Permeability and Pathology in APP/PS1 Mice. Neurobiology of Aging, 35, 1442-1452.
|
[26]
|
Michaud, J.P., Halle, M., Lampron, A., et al. (2013) Toll-Like Receptor 4 Stimulation with the Detoxified Ligand Monophosphoryl Lipid A Improves Alzheimer’s Disease-Related Pathology. PNAS, 110, 1941-1946.
https://doi.org/10.1073/pnas.1215165110
|